trending Market Intelligence /marketintelligence/en/news-insights/trending/MNvTtpbNUxKN9Z6PPamreQ2 content esgSubNav
In This List

Ascletis Pharma director resigns

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Ascletis Pharma director resigns

Ascletis Pharma Inc. said Wei Fu resigned from the board as a nonexecutive director on Dec. 24 due to other business commitments.

The company said Fu has no disagreement with the board.

China's Ascletis Pharma is an investment holding company that focuses on the development and commercialization of various drugs.